# VIRGINIA COMMONWEALTH UNIVERSITY: Hydrogen Sulfide for the Prevention of Cisplatin-Induced Atherosclerosis

**Lab Budget Score:** 25/100

| Field | Value |
|---|---|
| Organization | VIRGINIA COMMONWEALTH UNIVERSITY |
| Location | RICHMOND, VA |
| Project | Hydrogen Sulfide for the Prevention of Cisplatin-Induced Atherosclerosis |
| Project number | 5F31HL176081-02 |
| Mechanism | F31 |
| Institute | National Heart Lung and Blood Institute |
| Award | $47,070 |
| Awarded | 2026-09-09 |
| Project period | 2025-09-30 to 2027-09-29 |
| UEI | MLQFL4JSSAA9 |

## Why this score
- Award of $47,070.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11493706). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.